Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran

Microbial Drug Resistance

Volumn 14, Issue 4, 2008, Pages 273-279

  Doustdar, Farahnoosh ^a   Khosravi, Azar Dokht ^a   Farnia, Parissa ^b   Masjedi, Mohammad Reza ^b   Velayati, Ali Akbar ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CODON; GENETIC POLYMORPHISM; GENOTYPE; IRAN; MULTIGENE FAMILY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; IRAN; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; PEROXIDASES; PEROXIREDOXINS; PREDICTIVE VALUE OF TESTS; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 57749199676     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2008.0842     Document Type: Article

References (39)

1. Aktas, E., R. Durmaz, D. Yang, and Z. Yang. 2005. Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey. Microb. Drug Resist. 11:94-99.
2. Baker, L.V., T.J. Brown, O. Maxwell, A.L. Gibson, Z. Fang, M.D. Yates, and F.A. Drobniewski. 2005. Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC-46A polymorphism. Antimicrob. Agents Chemother. 49:1455-1464.
3. Banerjee, A., M. Sugantino, J.C. Sacchettini, and W.R. Jacobs, Jr. 1998. The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance. Microbiology 144:2697-2707.
4. Canetti, G., W. Fox, A. Khomenko, H.T. Mahler, N.K. Menon, D.A. Mitchison, N. Rist, and N.A. Smelev. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity test in tuberculosis control programmes. Bull. W.H.O. 41:21-43.
5. Cardoso, R.F., R.C. Cooksey, G.P. Morlock, P. Barco, L. Cecon, F. Forestiero, C.Q.F. Leite, D.N. Sato, M. de Lourdes Shikama, E.M. Mamizuka, R.D.C. Hirata, and M.H. Hirata. 2004. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob. Agents Chemother. 48:3373-3381.
6. Doorn, H.R., E.J. Kuijper, A. van der Ende, A.G. Welten, D. van Soolingen, P.E. de Haas, and J. Dankert. 2001. The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg → Leu mutation at codon 463 of katG are not associated. J. Clin. Microbiol. 39:1591-1594.
7. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M.C. Raviglione. 1999. For the WHO Global Surveillance and Monitoring Project. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA 282:677-686.
8. Espinal, M.A., A. Laszlo, L. Simonsen, F. Boulahbal, S.J. Kim, A. Reniero, S. Hoffner, H.L. Rieder, N. Binkin, C. Dye, R. Williams, and M.C. Raviglione. 2001. Global trends in resistance to antituberculosis drugs. N. Engl. J. Med. 344:1294-1303.
9. Farnia, P., M.R. Masjedi, M. Mirsaeidi, F. Mohammadi, J. Ghanavi, V. Vincent, M. Bahadori, and A.A. Velayati. 2006. Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients. J. Infect. 53:331-336.
10. Filliol, I., J.R. Driscoll, D. van Soolingen, B.N. Kreiswirth, G. Kremer, K. Valetudie, et al. 2002. Global distribution of Mycobacterium tuberculosis spoligotypes. Emerg. Infect. Dis. 8:1347-1349.
11. Hernando Hazbón, M., M. Brimacombe, M.V. del Valle, and M. Cavatore. 2006. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 50:2640-2649.
12. Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. Van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914.
13. Kent, P.T., and G.P. Kubica. 1985. Public health mycobacteriology: a guide for the level III laboratory. U.S. Department of Health and Human Services, Washington, DC, pp. 71-157.
14. Kiepiela, P., K.S. Bishop, A.N. Smith, L. Roux, and D.F. York. 2000. Genomic mutations in the katG, inhA, and ahpC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber. Lung Dis. 80:47-56.
15. Kim, S.Y., Y.J. Park, W.I. Kim, S.H. Lee, C.H. Chang, S.J. Kang, and C.S. Kang. 2003. Molecular analysis of isoniazid resistance in Mycobacterium tuberculosis isolates recovered from South Korea. Diagn. Microbiol. Infect. Dis. 47:497-502.
16. Lavender, C., M. Globan, A. Sievers, H. Billman-Jacobe, and J. Fyfe. 2005. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. Antimicrob. Agents Chemother. 49:4068-4074.
17. Lee, H., S.N. Cho, H.E. Bang, J.H. Lee, G.H. Bai, S.J. Kim, and J.D. Kim. 2000. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea. Int. J. Tuber. Lung Dis. 4:441-447.
18. Lee, S.H., S.Y. Kim, H.K. Kea, and Y. S. Hwang. 2001. The results of surveys of resistance to anti tuberculous drugs. Korean J. Clin. Microbiol. 4:98-99.
19. Mirsaeidi, M.S., P. Tabarsi, P. Farnia, G. Ebrahimi, M.W. Morris, M.R. Masjedi, A.A. Velayati, and D. Mansouri. 2007. Trends of drug resistant Mycobacterium tuberculosis in a tertiary tuberculosis center in Iran. Saudi Med. J. 28:544-550.
20. Mokrousov, I., O. Narvskaya, T. Otten, E. Limeschenko, L. Steklova, and B. Vyshnevskiy. 2002. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from Northwestern Russia, 1996 to 2001. Antimicrob. Agents Chemother. 46:1417-1424.
21. Musser, J.M., V. Kapur, D.L. Williams, B.N. Kreiswirth, D. Van Soolingen, and J.D.A. Van Embden. 1996. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J. Infect. Dis. 173:196-202.
22. Park, Y.K., S. Shin, S. Ryu, S.N. Cho, W.J. Koh, O.J. Kwon, Y.S. Shim, W.J. Lew, and G.H. Bai. 2005. Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. J. Microbiol. Methods 63:165-172.
23. Piatek, A.S., A. Telenti, M.R. Murray, H. El-Hajj, W.R. Jacobs, Jr., F.R. Kramer, and D. Alland. 2000. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob. Agents Chemother. 44:103-110.
24. Quemard, A., J.C. Sacchettini, A. Dessen, C. Vilcheze, R. Bittman, W.R. Jacobs, and J.S. Blanchard. 1995. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34:8235-8241.
25. Ramaswamy, S., and J.M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: update. Tuber. Lung Dis. 79:3-29.
26. Ramaswamy, S.V., R. Reich, S.J. Dou, L. Jasperse, X. Pan, A. Wanger, T. Quitugua, and E.A. Graviss. 2003. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47:1241-1250.
27. Rinder, H., K. Feldmann, E. Tortoli, J. Grosset, M. Casal, E. Richter, M. Rifai, V. Jarlier, M. Vaquero, S. Rush-Gerdes, E. Cambau, J. Gutierrez, and T. Loshher. 1999. Culture-independent prediction of isoniazid resistance in Mycobacterium tuberculosis by katG gene analysis directly from sputum samples. Mol. Diagn. 4:145-152.
28. Rinder, H., A. Thomschke, S. Rusch-Gerdes, G. Bretzel, K. Feldmann, M. Rifai, and T. Loscher. 1998. Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis. 17:508-511.
29. Sherman, D.R., K. Mdluli, M.J. Hickey, T.M. Arain, S.L. Morris, C.E. Barry III, and C.K. Stover. 1996. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272:1641-1643.
30. Sreevatsan, S., X. Pan, Y. Zhang, V. Deretic, and J.M. Musser. 1997. Analysis of the oxyR-ahpC region in isoniazid-resistant and susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob. Agents Chemother. 41:600-606.
31. Telenti, A., N. Honore, C. Bernasconi, J. March, A. Ortega, B. Heym, H. Takiff, and S.T. Cole. 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35:719-723.
32. Toungoussova, O.S., A.O. Mariandyshev, G. Bjune, P. Sandven, and D.A. Caugant. 2003. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family. Clin. Infect. Dis. 37:665-672.
33. Toungoussova, O.S., P. Sandven, A.O. Mariandyshev, N.I. Nizovtseva, G. Bjune, and D.A. Caugant. 2002. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel oblast, Russia. J. Clin. Microbiol. 40:1930-1937.
34. Tracevska, T., I. Jansone, L. Broka, O. Marga, and V. Baumanis. 2002. Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J. Clin. Microbiol. 40:3789-3792.
35. van Embden, J.D., M.D. Cave, J.T. Crawford, J.W. Dale, K.D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T.M. Shinnick, and P.M. Small. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.
36. van Rie, A., R. Warren, I. Mshanga, A.M. Jordaan, G.D. van der Spuy, M. Richardson, J. Simpson, R.P. Gie, D.A. Enarson, N. Beyers, P.D. van Helden, and T.C. Victor. 2001. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J. Clin. Microbiol. 39:636-641.
37. van Soolingen, D., P.E. de Haas, P.W. Hermans, and J.D. van Embden. 1994. DNA fingerprinting of Mycobacterium tuberculosis, Methods Enzymol. 235:196-205.
38. Velayati, A.A., P. Farnia, and M.R. Masjedi. 2006. The most prevalent Mycobacterium tuberculosis superfamilies among Iranian and Afghan TB cases. Scand. J. Infect. Dis. 38:463-468.
39. Zhang, M., J. Yue, Y.P. Yang, H.M. Zhang, J.Q. Lei, R.L. Jin, X.L. Zhang, and H.H. Wang. 2005. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol. 43:5477-5482.